Der Schlüssel zum Schloß II. Hansch‐Analyse, 3D‐QSAR und De novo‐Design

Pharmazie in unserer Zeit

Volumn 23, Issue 5, 1994, Pages 281-290

  Kubinyi, Hugo ^a  

^a BASF SE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATION; DRUG DESIGN; REVIEW; STATISTICAL MODEL; STRUCTURE ACTIVITY RELATION; DRUG ANALYSIS; DRUG RESEARCH; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROLYSIS; METHODOLOGY; STRUCTURE ANALYSIS;

DRUG DESIGN; MODELS, STATISTICAL; MOLECULAR CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T;

CHYMOTRYPSIN; GLYCINE; HIPPURIC ACID METHYL ESTER; HIPPURIC ACID PHENYL ESTER; N MESYLGLYCINE PHENYL ESTER DERIVATIVE; UNCLASSIFIED DRUG;

EID: 0028146777     PISSN: 00483664     EISSN: 16151003     Source Type: Journal    
DOI: 10.1002/pauz.19940230506     Document Type: Article

References (128)

1. Quantitative approach to biochemical structure-activity relationships
2. Quantitative Drug Design
3. A Comparison by QSAR, Crystallography, and Computer Graphics of the Inhibition of Various Dihydrofolate Reductases by 5-(X-Benzyl)-2,4-diamino-pyrimidines
4. Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, x-ray crystallography, and computer graphics in structure-activity analysis
5. Papain hydrolysis of X-phenyl-N-methanesulfonyl glycinates: A quantitative structure-activity relationship and molecular graphics analysis
6. Separation of electronic and hydrophobic effects for the papain hydrolysis of substituted N-benzoylglycine esters
7. QSAR: Quantitative Structure‐Activity Relationships in Drug Design (Proceedings of the 7th European Symposium on QSAR, Interlaken, 1988)
8. A Mathematical Contribution to Structure-Activity Studies
9. Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interactions with biological membranes
10. QSAR: Rational Approaches to the Design of Bioactive Compounds (Proceedings of the 8th European Symposium on QSAR, Sorrento, 1990)
11. Quantitative relationships between .alpha.-adrenergic activity and binding affinity of .alpha.-adrenoceptor agonists and antagonists
12. Multiple Regression and Principal Component Analysis of Antibacterial Activities of Sulfones and Sulfonamides in Whole Cell and Cell-Free Systems of Various DDS Sensitive and Resistant Bacterial Strains
13. Nature of anionic or α-site of cholinesterase
14. New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure
15. QSAR in Drug Design and Toxicology (Proceedings of the 6th European QSAR Symposium, Portoroz, 1986)
16. QSAR: Rational Approaches to the Design of Bioactive Compounds (Proceedings of the 8th European Symposium on QSAR, Sorrento, 1990)
17. The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses
18. Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies
19. Validation of QSAR's
20. HINT: A new method of empirical hydrophobic field calculation for CoMFA
21. In search of new lead compounds for trypanosomiasis drug design: A protein structure-based linked-fragment approach
22. Computer design of bioactive molecules: A method for receptor-based de novo ligand design
23. Rational modification of human synovial fluid phospholipase A2 inhibitors